Trial NCT00915590

View at ClinicalTrials.gov 
Org. Study IDs: 09-03-017
Secondary IDs: Protocol #09-03-017

Last trial update was posted on 2017-05-08

MeSH Interventions

Interleukin 1 Receptor Antagonist Protein

MeSH Conditions

Corneal Neovascularization Neovascularization, Pathologic

Other Conditions


Stopping Reasons

N/A

Limitations And Caveats

Enrollment goal for this study was set at 20 participants (10 for each treatment arm). After an interim analysis, the Principal Investigator decided to terminate the study and stop enrollment.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID